Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
12/01/2022 | Press release | Distributed by Public on 12/01/2022 06:17
Please select the service you want to use:
Smartlinks | Marsa Maroc SA | News | Finance | Security Markets | Fixed Income | Bonds | Security Markets | Company News | Top Company News | Corporate Debt | Corporate Bonds | Business Announcement | Transportation | Marine Transportation | Cruises | Travel, Leisure and Recreation Industry | Cruises | Public Companies | Terminal Management and Port Services Companies | Bourse de Casablanca
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact